Tenants

5M Biomed, LLC

Founded by a group of scientists specializing in life sciences, biomaterial engineering and medical imaging, 5M Biomed, LLC, is developing advanced biomedical technology to enable precision medicine. Using innovative technology, 5M Biomed provides solutions and technologies for in vitro diagnosis, precision and quantitative imaging, and therapeutic agent delivery platforms through novel bio-inspired magnetic nano-materials and molecularly targeted imaging methods.

Advac, LLC

Advac, LLC, is a vaccine research company founded by Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University. Kang is focused on designing and developing effective vaccines against viral diseases such as influenza and respiratory syncytial virus (RSV), improving understanding of vaccine-induced protective immune mechanisms, studying pathogen-induced inflammation, and developing anti-inflammatory therapeutics.

Cell Constructs, Inc. (CCI)

Cell Constructs, Inc., was formed in 2008 to develop and evaluate proof-of-principle product concepts based upon the use of adult human stem cells. Its biomaterials facilitate efficient use of stem cells in regenerative healing and tissue engineering applications. CCI is developing ProgenaGraft™ for the regenerative healing of chronic wounds such as diabetic foot ulcers.

Chembind, LLC

Chembind, LLC, is a pharmaceutical company dedicated to promoting the research and development of sugar chemistry, glycobiology and medicine. The company also works to invent and design new isotope labeled compounds, antibody-drug conjugates and in vitro diagnosis reagents.

NanoResearch, Inc.

NanoResearch, Inc., works to invent and design new manufacturing enterprise and/or license new nanomaterials, energy storage materials, energy storage devices and smart mechanical products.

ProDa BioTech, LLC

Research Projects International, LLC

ResonanceDx, Inc.

ResonanceDx, Inc., is a point-of-care diagnostic device startup company. Their novel testing platform uses Bulk Acoustic Resonance Sensing (BARS) for rapid detection of biomolecules. These diagnostic tests can be performed on site in a hospital ER or ICU, clinic, doctor’s office, pharmacy or in the field in real time. In addition to filling the immediate need for SARS-CoV-2 testing, their multi-resonator sensor device allows for testing and analysis of four or more analytes in a single test.